ExploreWatchlistsPricing
  1. US-listed companies
  2. REGENEREX PHARMA, INC.
  3. Financials
  4. Cash and cash equivalents

REGENEREX PHARMA, INC. (RGPX)

Market cap
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Mar 31, 20251+175444.35%
Mar 31, 20240-67.22%
Mar 31, 20230-57.01%
Mar 31, 20220-61.75%
Mar 31, 20210+26.41%
Mar 31, 20200-93.83%
Mar 31, 20190+5024.19%
Mar 31, 20180+31.01%
Nov 30, 20140+740.13%
Nov 30, 20130-97.98%
Nov 30, 20120

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat